Financials data is unavailable for this security.
View more
Year on year Metropolis Healthcare Ltd had net income fall -10.54% from 1.43bn to 1.28bn despite a 5.18% increase in revenues from 11.48bn to 12.08bn. An increase in the selling, general and administrative costs as a percentage of sales from 50.10% to 52.76% was a component in the falling net income despite rising revenues.
| Gross margin | 78.91% |
|---|---|
| Net profit margin | 11.56% |
| Operating margin | 16.32% |
| Return on assets | 9.47% |
|---|---|
| Return on equity | 13.27% |
| Return on investment | 11.23% |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Metropolis Healthcare Ltd fell by 62.15m. However, the company earned 2.64bn from its operations for a Cash Flow Margin of 21.82%. In addition the company used 894.12m on investing activities and also paid 1.81bn in financing cash flows.
| Cash flow per share | 49.06 |
|---|---|
| Price/Cash flow per share | 43.02 |
| Book value per share | 231.05 |
|---|---|
| Tangible book value per share | 67.72 |
More ▼
Balance sheet in INRView more
| Current ratio | 1.64 |
|---|---|
| Quick ratio | 1.49 |
| Total debt/total equity | 0.16 |
|---|---|
| Total debt/total capital | 0.1376 |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items dropped -10.59%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| EPS growth(5 years) | 0.7017 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 10.68 |
